When this idea is extended to tumor field, DRAXIN is reported to be a key factor in the progress of lung adenosquamous carcinoma via the regulation of cell proliferation and apoptosis (Sato et al. 2018). Here, DRAXIN is linked to adenosquamous lung carcinoma.